Global Engage Microbiome & Probiotics R&D and Business Collaboration Forum

The Hague, The Netherlands
23/04/2024 – 24/04/2024


About the event

Global Engage is pleased to announce the 12th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum, which is confirmed to be held on April 23-24 2024 in The Netherlands and co-located with the 6th Skin Microbiome & Cosmeceuticals Congress.

This world-renowned event which attracted 265 industry, academic, and investment leaders last year, enables the discussion of the most scientific cutting-edge microbiome, probiotics and skin-based research; the challenges and opportunities in translating research towards commercialisation, and partnerships and collaborations that secure investment. With 3 conferences and 8 tracks, there is ample content to learn from top scientists, network and broaden your connections and should you wish showcase your work in the poster presentation sessions or get involved in the interactive panel and roundtable discussions.

ILSI Europe session

A session will present the work of the ILSI Europe expert group on Prebiotics and Cognition commissionned by the Prebiotics Task Force.

Track: Gut Brain Axis
Session time: Tuesday 23rd April 2024 | 12:40 - 13:10
Session title: Prebiotics and Cognition - A Review and Future Directions for Human Intervention Studies
Prebiotics have been tested in preclinical and human intervention studies for their effects on cognition. In this presentation, these studies are reviewed together with a list of recommendations to move the field forward. Specifically, we stress the need to perform studies in healthy participants that test the potential “rescuing” effects of prebiotics under conditions where cognition may be transiently compromised. Ultimately, such studies would allow better estimation of the magnitude.
Speaker: Franco Ruiz, PhD Student at KU Leuven (Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research for Gastrointestinal Disorders (TARGID) division, Department of Chronic and Metabolic Diseases)

Further information